Wong Julie, Witherspoon Luke, Wu Eugenia, Sheikholeslami Sara, Liao Wen, Yuen Wallace, Bentley Jenna, Zarowski Christine, Sundar Monita, Elliott Stacy, Higano Celestia S, Flannigan Ryan
Department of Urologic Sciences, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Department of Urology, The Ottawa Hospital, Ottawa, ON K1H 8M2, Canada.
J Clin Med. 2020 Oct 20;9(10):3363. doi: 10.3390/jcm9103363.
Prostate cancer (PC) treatment leads to impairment of sexual function. The Prostate Cancer Supportive Care (PCSC) Program's Sexual Rehabilitation clinic (SRC) assists patients and their partners with sexual recovery using a biopsychosocial approach to rehabilitation. This study characterizes patients seen in the SRC between July 2013-1 July 2019. Data was retrospectively abstracted from clinic records. In total, 965 patients were seen over 3391 appointments during the study period. Median age (standard deviation (SD)) was 66 years (SD = 7.1), 82.0% were partnered, yet 81.7% attended appointments alone. 88.0% were treated with surgery, 5.1% with brachytherapy, 3.7% with external beam radiation (EBRT), 1.8% with combined brachytherapy and EBRT, and 1.4% with androgen deprivation therapy. In total, 708 patients (73.4%) attended ≥1 follow-up appointment. Median time (SD) between end of prostate cancer treatment to first SRC appointment was 270 days (range 0-7766). The mean (SD) self-reported overall sexual satisfaction (extracted from International Index of Erectile Function-5 (IIEF-5)) significantly increased both with erectile aids (1.69 (SD = 1.52) to 2.26 (SD = 1.66), < 0.001, = 148) and without erectile aids (1.71 (SD = 1.44) to 2.35 (SD = 1.57), < 0.001, = 235). This study provides guidance for further investigation to refine treatment, wait-times, support, and/or resource offerings in this type of program.
前列腺癌(PC)治疗会导致性功能障碍。前列腺癌支持性护理(PCSC)项目的性康复诊所(SRC)采用生物心理社会康复方法,帮助患者及其伴侣恢复性功能。本研究对2013年7月至2019年7月1日期间在SRC就诊的患者进行了特征描述。数据是从临床记录中回顾性提取的。在研究期间,总共965名患者进行了3391次预约就诊。中位年龄(标准差(SD))为66岁(SD = 7.1),82.0%的患者有伴侣,但81.7%的患者独自就诊。88.0%的患者接受了手术治疗,5.1%接受了近距离放射治疗,3.7%接受了外照射放疗(EBRT),1.8%接受了近距离放射治疗与EBRT联合治疗,1.4%接受了雄激素剥夺治疗。总共有708名患者(73.4%)进行了≥1次随访预约。前列腺癌治疗结束至首次SRC预约的中位时间(SD)为270天(范围0 - 7766天)。自我报告的总体性满意度(从国际勃起功能指数-5(IIEF-5)中提取)的平均值(SD)在使用勃起辅助器具时(从1.69(SD = 1.52)提高到2.26(SD = 1.66),< 0.001, = 148)和未使用勃起辅助器具时(从1.71(SD = 1.44)提高到2.35(SD = 1.57),< 0.001, = 235)均显著提高。本研究为进一步研究提供了指导,以优化此类项目中的治疗、等待时间、支持和/或资源提供。